The Extraordinary But Uncertain Growth Of The COVID-19 Market
Q1 Sales Of Leading Products
Executive Summary
The value of the COVID-19 market reached more than $8bn in the first quarter, fuelled by mRNA-based vaccines, but the future growth of the sector depends on the rather unpredictable course of the pandemic, and the response of healthcare providers and countries.